Search
Close this search box.

ALPHA1 ANTITRYPSIN DEFICIENCY

ELIGIBILITY & REQUIREMENTS

  • 18 – 70 years old.
  • Diagnosis of Alpha1 Antitrypsin Deficiency with evidence of emphysema.
  • No flare up of the chest in the last 5 weeks prior to the first visit.
  • No cancer in last 5 years.

WHAT'S INVOLVED

  • You will be required to come once a week for 3 years for treatment including health checks to the Institute for Respiratory Health at Level 2, 6 Verdun Street, Nedlands WA 6009.
  • CT scans of your lungs will be required on 5 occasions throughout the trial.

STUDY OUTLINE

This study is:

  • Approximately 3 years.
  • Phase III.
  • Safety and Efficacy of two dose regimes of the study drug.
  • Weekly infusions.

To find out if this trial is suitable for you please register below, or contact our Clinical Trials Team at clinicaltrials@resphealth.uwa.edu.au or phone 6151 0888.

REGISTER YOUR INTEREST IN THIS CLINICAL TRIAL

Address
Scroll to Top